Isabelle Valo
Overview
Explore the profile of Isabelle Valo including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
38
Citations
640
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Communie A, Valo I, Soulie P, Grimaux X
An Bras Dermatol
. 2024 Aug;
99(6):987-989.
PMID: 39112286
No abstract available.
2.
Perret R, Malaka Z, Velasco V, Llamas-Gutierrez F, Ropars M, Linck P, et al.
Am J Surg Pathol
. 2023 May;
47(7):801-811.
PMID: 37170907
Giant cell tumors (GCTs) with high mobility group AT-Hook 2 ( HMGA2 )::nuclear receptor corepressor 2 ( NCOR2 ) fusion are rare mesenchymal tumors of controversial nosology, which have been...
3.
Sourty B, Kerdraon O, Verriele V, Raro P, Valo I
Ann Pathol
. 2022 May;
42(4):345-349.
PMID: 35595595
No abstract available.
4.
De Pinieux G, Karanian M, Le Loarer F, Le Guellec S, Chabaud S, Terrier P, et al.
PLoS One
. 2021 Feb;
16(2):e0246958.
PMID: 33630918
Background: Since 2010, nationwide networks of reference centers for sarcomas (RREPS/NETSARC/RESOS) collected and prospectively reviewed all cases of sarcomas and connective tumors of intermediate malignancy (TIM) in France. Methods: The...
5.
Nader J, Boissard A, Henry C, Valo I, Verriele V, Gregoire M, et al.
Cancers (Basel)
. 2020 Sep;
12(9).
PMID: 32867073
Malignant mesothelioma (MM) still represents a devastating disease that is often detected too late, while the current effect of therapies on patient outcomes remains unsatisfactory. Invasiveness biomarkers may contribute to...
6.
Valo I, Raro P, Boissard A, Maarouf A, Jezequel P, Verriele V, et al.
Proteomics
. 2019 Jul;
19(21-22):e1800446.
PMID: 31318138
Human olfactomedin-4 (OLFM4) is a secreted protein involved in a variety of cellular functions including proliferation, differentiation, apoptosis, and cell adhesion. OLFM4 expression has been studied in several tumor types...
7.
Lesluyes T, Baud J, Perot G, Charon-Barra C, You A, Valo I, et al.
Mod Pathol
. 2019 Jun;
32(12):1786-1794.
PMID: 31243333
Post-radiation sarcomas are rare secondary cancers arising from radiation therapies. To date, few genetic specificities have been described for such malignancies and the oncogenesis of sarcomas with complex genetics (both...
8.
Croce S, Ducoulombier A, Ribeiro A, Lesluyes T, Noel J, Amant F, et al.
Mod Pathol
. 2018 Jan;
31(5):816-828.
PMID: 29327710
The diagnosis of a uterine smooth muscle lesion is, in the majority of cases, straightforward. However, in a small number of cases, the morphological criteria used in such lesions cannot...
9.
de Carne Trecesson S, Souaze F, Basseville A, Bernard A, Pecot J, Lopez J, et al.
Nat Commun
. 2017 Oct;
8(1):1123.
PMID: 29066722
In tumours, accumulation of chemoresistant cells that express high levels of anti-apoptotic proteins such as BCL-X is thought to result from the counter selection of sensitive, low expresser clones during...
10.
Touchefeu Y, Provost-Dewitte M, Lecomte T, Morel A, Valo I, Mosnier J, et al.
Eur J Gastroenterol Hepatol
. 2016 Sep;
28(12):1394-1399.
PMID: 27606947
Introduction: The assessment of risk factors of cancer recurrence in patients with stage II colon cancer (CC) is crucial. Our aim was to study the clinical, histological, and molecular features...